LCD L36159: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) — Noridian
Policy LCD-L36159 · Hematology
New genetic testing guidelines for thrombophilia impact billing.
Code intelligence
I82.91 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code I82.91.
Elevated code riskView ICD-10 detail
Signal breakdown
2 shown · 2 total in platform
Risk: Elevated
0
Critical
0%
2
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
Proposed LCD DL40259: MolDX: Genetic Testing for Hereditary Thrombophilia — CGS
Policy LCD-DL40259 · Hematology
Impact on genetic testing billing for thrombophilia.
Audit documentation
Building an audit file that includes I82.91?
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Hematology audit pack — $349One-time purchase · not a subscription